🔎 Trials Near Me

Utama › Limfoma › Florida

Kajian klinikal Limfoma di Florida

25 kajian untuk Limfoma sedang mencari peserta di lokasi di Florida.

Bandar di Florida

Teks kajian rasmi (Bahasa Inggeris)

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Moffit Cancer Center, Tampa
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07192471

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

  • Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07015242

Precise Oncology Interventions in Nutrition and Training (OnPoint)

  • University of Miami, Miami
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06534918

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  • University of Miami, Coral Gables
  • Florida Cancer Specialists, Sarasota
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07221500

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  • Research Site, Miami
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06137144

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Johns Hopkins All Children's Hospital, St. Petersburg
Mengambil pesertaFasa 1/2
12 Months – 21 Years · Semua jantina · Dikemas kini 11 Sep 2026 · NCT04870944

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  • AdventHealth Cancer Institute, Orlando
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06624085

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  • University of Miami, Coral Gables
  • Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06084936

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • Mayo Clinic, Jacksonville
  • Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT04588922

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • Mayo Clinic, Clinical Trials Referral Office, Jacksonville
Mengambil pesertaFasa 1/2
Umur 13 hingga 90 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Mayo Clinic Florida, Jacksonville
  • AdventHealth, Orlando
  • Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

  • Baptist Health Miami Cancer Institute, Miami
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • University of Miami, Miami
  • Florida Cancer Specialists, Sarasota
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT05131022

CD4CAR for CD4+ Leukemia and Lymphoma

  • University of Miami Sylvester Comprehensive Cancer Center, Miami
Mengambil pesertaFasa 1
Umur 12 ke atas · Semua jantina · Dikemas kini 24 Jun 2026 · NCT03829540

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

  • Dren Investigational Site, Tampa
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Jun 2026 · NCT05475925

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  • University of Miami, Miami
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jun 2026 · NCT05663502

xDRIVE for Florida-based Cancer Patients

  • First Ascent Biomedical, Miami
Mengambil peserta
Semua umur · Semua jantina · Dikemas kini 19 Mei 2026 · NCT07167381

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • Nemours Children's Clinic-Jacksonville, Jacksonville
  • Nemours Children's Hospital, Orlando
  • dan 2 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 18 Mei 2026 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Mayo Clinic, Jacksonville
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • ASCLEPES Research Centers, Weeki Wachee
Mengambil pesertaFasa 1/2
Umur 12 hingga 95 · Semua jantina · Dikemas kini 15 Apr 2026 · NCT04329728

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

  • University of Miami Sylvester Cancer Center, Miami
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mac 2026 · NCT05800366

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

  • Sylvester Comprehensive Cancer Center, Miami
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Feb 2026 · NCT05745285

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

  • Hematology-Oncology Associates of the Treasure Coast, Port Saint Lucie
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Feb 2026 · NCT05892718

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Miami Cancer Institute, Miami
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 ke atas · Semua jantina · Dikemas kini 20 Jan 2026 · NCT05366881

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.